Clinical Trial 47028

Middleburg Heights, OH 44130


A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of REL-1017 as Adjunctive Treatment of Major Depressive Disorder (The RELIANCE-II Study).

Qualified Participants Must:

• Aged 18 to 65 years
• Must be on 1 to 2 antidepressants for at least 6 weeks
• Have a BMI 18kg - 30kg
• Willing and able to commit to meet all study requirments, adhere to both approved ADT and study drug regimen, and complete all assessments and all scheduled visits, per Investigator judgement

Qualified Participants May Receive:

Compensation for time and travel upon qualifications and enrollment into the study. 

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.